Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA (R), Because of a Previous Intolerance to cART. PRO-STR Study

Autor: Podzamczer, D, Rozas, N, Domingo, P, Miralles, C, van den Eynde, E, Romero, A, Deig, E, Knobel, H, Pasquau, J, Antela, A, Clotet, B, Geijo, P, de Castro, ER, Casado, MA, Munoz, A, Gonzalez, JS, Mayorga, MI, Alfaro, EM, Sepulveda, MA, Yzusqui, M, Farre, JRB, Zapata, MR, Luque, PB, Carrasco, AB, Lorenzo, JF, Torrella, A, Serrano, XS, Aren, JD, Fernandez, P, Hurtado, ERD

Publikováno v: CURRENT HIV RESEARCH
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Background: To investigate the impact of switching from stable Combined Antiretroviml Therapy (cART) to single-tablet regimen (RPV/FTC/TDF=EVIPLERA (R) /COMPLERA (R)) on patient-reported outcomes in HIV-infected adults who cannot tolerate previous cA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::b5db43c50329a3be7fc909873c53cf29
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3996